J. Buijs, A. S. M. Dofferhoff, J. W. Mouton, J. H. T. Wagenvoort, J. W

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

In-vitro interaction of azithromycin and fluoroquinolones against gram-positive and gram-negative bacteria Matthew W. Ruble, Deborah H. Gilbert, Stephen.

Defining an extended-spectrum β-lactamase

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

M.A.C. Broeren, Y. Maas, E. Retera, N.L.A. Arents

Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between.

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin- resistant Acinetobacter baumannii X. Vila-Farres, C. Garcia.

Migrant health—a cause for concern?

Defining an extended-spectrum β-lactamase

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.

J.-P. Van geertruyden Clinical Microbiology and Infection

O. Clerc, G. Greub Clinical Microbiology and Infection

Pseudomonas aeruginosa diversity in distinct paediatric patient groups

Management of post-neurosurgical meningitis: narrative review

Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries J.A. Otter, N.T. Mutters, E. Tacconelli, A.

A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU P.G. Higgins, H. Wisplinghoff, O. Krut, H.

A.E. Muller, U. Theuretzbacher, J.W. Mouton

The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents S. Brown, S.G.B. Amyes Clinical.

Louis Pasteur, from crystals of life to vaccination

A.G.G. Lødeng, C. Ahlén, H. Lysvand, L.H. Mandal, O.J. Iversen

Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice? T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt

Escherichia coli native valve endocarditis

A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals M. Nagao Clinical Microbiology and.

Morphological changes induced by imipenem and meropenem at sub-inhibitory concentrations in Acinetobacter baumannii M. Bernabeu-Wittel, A. García-Curiel,

Pathophysiology of in-vitro induced filaments, spheroplasts and rod-shaped bacteria in neutropenic mice J. Buijs, A.S.M. Dofferhoff, J.W. Mouton, J.W.M.

H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi

Vector control: a cornerstone in the malaria elimination campaign

Pharmacodynamics of doxycycline

Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.

Training for the infectious diseases speciality in Norway

Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria Inga Odenholt, Elisabeth Löwdin,

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Levofloxacin in the treatment of ventilator-associated pneumonia

R. Bitterman, M. Paul, D. Polak, Y. Geffen

Metagenomics and probiotics

T.M. File Clinical Microbiology and Infection

Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases L. Romero, L. López,

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures A. Makristathis, S. Riss, A.M. Hirschl

Clinical infection services—the Leiden experience

C. Gagliotti, L. Nobilio, M.L. Moro

Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit S. Nseir, C. Blazejewski, R. Lubret,

Statin use and clinical outcomes among pneumonia patients

P. Kaltsas, S. Want, J. Cohen Clinical Microbiology and Infection

Clinical Microbiology and Infection

I. Bitar, A. Piazza Clinical Microbiology and Infection

Clinical Microbiology and Infection

W. Eugene Sanders, Christine C. Sanders

O. Clerc, G. Greub Clinical Microbiology and Infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

F.J. Pastor, J. Guarro Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Predominance of SHV-5 β-lactamase in enteric bacteria causing community-acquired urinary tract infections in Bosnia and Herzegovina S. Uzunovic-Kamberovic,

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

Assessment of the usefulness of performing bacterial identification and antimicrobial susceptibility testing 24 h a day in a clinical microbiology laboratory

Antibiotic overconsumption and resistance in Turkey

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G. Kahlmeter Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

B. Martha, D. Croisier, A. Fanton, K. Astruc, L. Piroth, F. Huet, P

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Concentration-dependency of β-lactam-induced filament formation in Gram-negative bacteria J. Buijs, A.S.M. Dofferhoff, J.W. Mouton, J.H.T. Wagenvoort, J.W.M. van der Meer Clinical Microbiology and Infection Volume 14, Issue 4, Pages 344-349 (April 2008) DOI: 10.1111/j.1469-0691.2007.01940.x Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Viable counts following incubation of Escherichia coli ATCC 25922 for 4 h in the presence of varying concentrations of ceftazidime or cefotaxime. Clinical Microbiology and Infection 2008 14, 344-349DOI: (10.1111/j.1469-0691.2007.01940.x) Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Examples of morphological experiments showing the appearance (x100) of untreated cells (left), short filaments and long filaments (right) of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii. Clinical Microbiology and Infection 2008 14, 344-349DOI: (10.1111/j.1469-0691.2007.01940.x) Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions